Company
Sionnatx
Redefining what’s possible in cystic fibrosis treatment
Also known as Sionna Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Founded
- 2019
- sionnatx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.
Loading relationship preview